Objectives: A post-marketing surveillance (PMS) study was conducted to evaluate the efficacy and tolerability of treatment with moxifloxacin 400mg once daily in patients with acute exacerbations of ...
A total of 7223 patients with AECB treated in general practices across Germany between 1 November 2000 and 30 July 2001 were included for analysis in this PMS study. 2418 physicians recruited patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results